Pathophysiology of preeclampsia: links with implantation disorders

Eur J Obstet Gynecol Reprod Biol. 2004 Aug 10;115(2):134-47. doi: 10.1016/j.ejogrb.2003.12.030.

Abstract

The phenomenon of implantation anchors the embryo into the uterine wall and produces a hemochorial placenta that maintains the pregnancy and fetal growth. Implantation and placentation are intimately linked and cannot be dissociated either in time or in space. Preeclampsia is characterized by hypertension and proteinuria. It is secondary to an anomaly of the invasion of the uterine spiral arteries by extra-villous cytotrophoblast cells, associated with local disruptions of vascular tone, of immunological balance and inflammatory status, and sometimes with genetic predispositions. Preeclampsia is a disease of early pregnancy, a form of incomplete spontaneous abortion, but is expressed late in pregnancy. Aspirin may play a favorable role in implantation which is related to the genesis of preeclampsia and some cases of intra-uterine growth restriction. The most important points in obtaining a preventive effect from low-dose aspirin during the pregnancy are early treatment (before 13 weeks of gestation) and the prescription of a sufficient dose (more than 100 mg per day).

Publication types

  • Review

MeSH terms

  • Anti-Inflammatory Agents, Non-Steroidal / therapeutic use
  • Aspirin / therapeutic use
  • Embryo Implantation / immunology*
  • Embryo Implantation / physiology
  • Female
  • Humans
  • Pre-Eclampsia / immunology*
  • Pre-Eclampsia / physiopathology*
  • Pre-Eclampsia / prevention & control
  • Pregnancy
  • Trophoblasts / immunology*
  • Trophoblasts / physiology

Substances

  • Anti-Inflammatory Agents, Non-Steroidal
  • Aspirin